PhD in Biomedical Sciences and Biotechnology

 

Home –  PhD students –  Faculty –  Seminars

 

        1. D. Campioni , V. Gentili , F. Cavazzini , D. Bortolotti , EP. Nacheva , A. Cuneo , D. Di Luca, R. Rizzo. Detection of inherited chromosomally integrated HHV-6 (ciHHV-6) in a marker chromosome. European J Haematol 2017; in press. doi: 10.1111/ejh.12872.
        2. AB. Laaribi, D. Bortolotti, N. Hannachi, A. Mehri, O. Hazgui, HB. Yahia, W. Babay, M. Belhadj, H. Chaouech, S. Yacoub, A. Letaief, I. Ouzari, A. Boudabous, D. Di Luca, J. Boukadida, R. Rizzo, I. Zidi. Increased levels of soluble HLA-G molecules in Tunisian patients with chronic hepatitis B infection. J Viral Hepat. 2017; in press. doi: 10.1111/jvh.12718
        3. E. Eliassen, R. Marci,  D. Di Luca, R. Rizzo. The use of heparin in infertility and recurrent pregnancy loss: Are its antiviral properties at play?  Medical Hypotheses 2017; 102: 41-47.
        4. R. Rizzo , I. Farina , D. Bortolotti , E. Galuppi, M. Padovan, D. Di Luca , M. Govoni.The dimeric form of HLA-G molecule is associated with the response of early rheumatoid arthritis (ERA) patients to methotrexate. Clinical Rheumatology 2017; 36: 701-705.
        5. R. Rizzo , E. Fainardi, N. Rouas-Freiss , F. Morandi. The Role of HLA-Class Ib Molecules in Immune-Related Diseases, Tumors, and Infections 2016. J Immunol Research 2017; 2017: 2309574.
        6. N. Ben Fredj, K. Sakly, D. Bortolotti, M. Aissi, M. Frih-Ayed, A. Rotola, E. Caselli , F. Cura, N. Sakly , M. Aouni, D. Di Luca, R. Rizzo. The association between functional HLA-G 14 bp insertion/deletion and +3142 C > G polymorphisms and susceptibility to multiple sclerosis. Immunology Letters 2016; 180: 24-30
        7. R. Rizzo, G. Bergamini, D. Bortolotti, T. Leal, C. D’Orazio, E. Pintani, L. Melchiorri, E. Zavatti, B.M. Assael, C. Sorio, P. Melotti. HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients. Future Microbiol, 2016 11 (3): 363-73.
        8. R. Rizzo, L. Gabrielli, D. Bortolotti, V. Gentili, G. Piccirilli, A. Chiereghin, C. Pavia, S. Bolzani, B. Guerra, G. Simonazzi, F. Cervi, MG. Capretti, E. Fainardi, D. Di Luca, MP. Landini, T. Lazzarotto. Study of soluble HLA-G in congenital human cytomegalovirus infection. J Immunol Research 2016; 2016: 3890306.
        9. R. Rizzo, S. Pietrobon, E. Mazzoni, D. Bortolotti, F. Martini, M. Castellazzi, I. Casetta, E. Fainardi, D. Di Luca, E. Granieri, M. Tognon; Emilia-Romagna network for Multiple Sclerosis (ERMES) study group. Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis. J Transl Med. 2016; 14(1):216.
        10. D. Bortolotti, C. Trapella, T. Bernardi, R. Rizzo. Letter to the Editor: Antimicrobial properties of mucus from the brown garden snail Helix aspersa. Br J Biomed Sci. 2016; 73(1):49-50.
        11. R. Marci, V. Gentili, D. Bortolotti, G. Lo Monte, E. Caselli, S. Bolzani, A. Rotola, D. Di Luca, R. Rizzo. Presence of HHV-6A in Endometrial Epithelial Cells from Women with Primary Unexplained Infertility. PLoS One. 2016; 11(7): e0158304.
        12. R. Rizzo, D. Bortolotti, E. Fainardi, V. Gentili, S. Bolzani, E. Baldi, I. Casetta, E. Granieri, A. Rotola, R. Furlan, D. Di Luca. KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in Multiple Sclerosis patients. J Neuroimmunol. J Neuroimmunol. 2016 May 15;294:1-5.
        13. A. Borghi, M D’Accolti, R. Rizzo, A. Virgili, D. Di Luca, M. Corazza, E. Caselli. High prevalence of specific KIR types in patients with HHV-8 positive cutaneous vascular lesions: a possible predisposing factor? Archives Dermatol Res. 2016 308 (5): 373-7.
        14. D. Bortolotti, C. Trapella, T. Bernardi, R. Rizzo. Antimicrobial properties of mucus from the brown garden snail Helix aspersa. British J Biomed Science. 2016, 73 (1): 49-50.
        15. I. Zidi, A. B. Laaribi, D. Bortolotti, M. Belhadj, A. Mehri, H. B. Yahia, W. Babay, H. Chaouch, N. Zidi, A. Letaief, S. Yacoub, J. Boukadida, D. Di Luca, N. Hannachi, R. Rizzo. HLA-E polymorphism and soluble HLA-E plasma levels in chronic HBV hepatitis. HLA. 2016, 87 (3): 153-9.
        16. I. Zidi, N. Kharrat, R. Sebai, N. Zidi, HB. Yahia, A. Bouaziz, H. Rifi, A. Mezlini, R. Rizzo. Pregnancy and breastfeeding: a new theory for sHLA-G in breast cancer patients? Immunol Res. 2016, 64 (2): 636-9.
        17. I. Zidi, R. Rizzo, A. Bouaziz, AB. Laaribi, N. Zidi, D. Di Luca, H. Tlili, D. Bortolotti. sHLA-G1 and HLA-G5 levels are decreased in Tunisian women with multiple abortion. Hum Immunol. 2016 77 (4): 342-5.
        18. I. Zidi, N. Kharrat, R. Abdelhedi, AB. Hassine, AB. Laaribi, HB. Yahia, N. Abdelmouleh, L. Abid, A. Rebai, R. Rizzo. Nonclassical human leukocyte antigen (HLA-G, HLA-E, and HLA-F) in coronary artery disease. Hum Immunol. 2016 77 (4): 325-9.
        19. D. Bortolotti, J. LeMaoult, C. Trapella, D. Di Luca, ED. Carosella, R. Rizzo. Pseudomonas aeruginosa quorum sensing molecule N-(3-oxododecanoyl)-homoserine-L-lactone (3-o-C12-HSL) induces HLA-G expression in human immune cells. Infect Immun. 2015;  10:3918-25.
        20. R. Rizzo, MC. Zatelli, A. Rotola, E. Cassai, E. Degli Uberti, D. Di Luca, E. Caselli. Increase in peripheral CD3-CD56brightCD16- natural killer cells in Hashimoto’s thyroiditis associated with HHV-6 infection. Advances Microbiol, Infectious Diseases Public Health. 2015; 897: 113-20.
        21. D. De Lucia, OM. Lucio, B. Musio, A. Bender, M. Listing, S. Dennhardt, A. Koeberle, U. Garscha, R. Rizzo, S. Manfredini, O. Werz, SV. Ley. Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors. Eur J Med Chem. 2015;101: 573-583.
        22. M. Castellazzi, S. Delbue, F. Elia, M. Gastaldi, D. Franciotta, R. Rizzo, T. Bellini, R. Bergamaschi, E. Granieri, E. Fainardi. Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment. Dis Markers. 2015; 2015:901312.
        23. E. Fainardi, D. Bortolotti, S. Bolzani, M. Castellazzi, C. Tamborino, G. E. Roversi, Baldi, ML. Caniatti, I. Casetta, V. Gentili, E. Granieri, R. Rizzo; ERMES study group. Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis. Mult Scler. 2016; 22(2): 245-9.
        24. E. Caselli, D. Campioni, F. Cavazzini, V. Gentili, D. Bortolotti, A. Cuneo, D. Di Luca, R. Rizzo. Acute human herpesvirus-6A infection of human mesothelial cells modulates HLA molecules. Arch Virol. 2015; 160 (9): 2141-9.
        25. V. Cirello, R. Rizzo, M. Crippa, I. Campi, D. Bortolotti, S. Bolzani, C. Colombo, G. Vannucchi, MA. Maffini, F. de Liso, S. Ferrero, P. Finelli, L. Fugazzola. Fetal cell microchimerism: a protective role in autoimmune thyroid diseases. Eur J Endocrinol. 2015;173(1):111-8.
        26. I. Zidi, H. Ben Yahia, D. Bortolotti, L. Mouelhi, AB. Laaribi, S. Ayadi, N. Zidi, F. Houissa, R. Debbech, A. Boudabous, T. Najjar, D. Di Luca, R. Rizzo. Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease. Int Immunol. 2015; 27(6): 289-96.
        27. R. Rizzo, D. Bortolotti, S. Bolzani, E. Fainardi. HLA-G Molecules in Autoimmune Diseases and Infections. Front Immunol. 2014; 5:592.
        28. JM. Sanz, S. Falzoni, R. Rizzo, F. Cipollone, G. Zuliani, F. Di Virgilio. Possible protective role of the 489C>T P2X7R polymorphism in Alzheimer's disease. Exp Gerontol. 2014; 60:117-9.
        29. M. Castellazzi, C. Contini, C. Tamborino, F. Fasolo, G. Roversi, S. Seraceni, R. Rizzo, E. Baldi, MR. Tola, T. Bellini, E. Granieri, E. Fainardi. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies. J Neuroinflammation. 2014; 11:188.
        30. R. Rizzo, G. Lo Monte, D. Bortolotti, A. Graziano, V. Gentili, D. Di Luca, R. Marci. Impact of Soluble HLA-G Levels and Endometrial NK Cells in Uterine Flushing Samples from Primary and Secondary Unexplained Infertile Women. Int J Molecular Sciences, 2015; 11 (7): 5510-6.
        31. N. Malagutti, F. Stomeo, S. Pelucchi, R. Ronchin, M. Ceccon, G. Malacrida,  A. Ciorba, A. Pastore,  M. Borin,  R. Rizzo. Analysis of IL-10 gene sequence in patients with sinonasal polyposis Int J Immunopathol Pharmacol, 2015; 28 (3): 434-9.
        32. A.B. Laaribi, I. Zidi, N. Hannachi, H. Ben Yahia, H. Chaouch, D. Bortolotti, N. Zidi, A. Letaief, S. Yacoub, A. Boudabous, R. Rizzo, J. Boukadida. Association HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitis. J Viral Hepat; 2015; 22 (10): 835-41.
        33. G. Amodio, M. Comi, D. Tomasoni, ME. Gianolini, R. Rizzo, J. LeMaoult, MG. Roncarolo, S. Gregori. HLA-G expression levels influence the tolerogenic activity of human DC-10. Haematologica. 2015; 100(4):548-57.
        34. O. Brugière, G. Thabut, I. Krawice-Radanne, R. Rizzo, G. Dauriat, C. Danel, C. Suberbielle, H. Mal, M. Stern, C. Schilte, M. Pretolani, E.D. Carosella, N. Rouas-Freiss. Role of HLA-G as a Predictive Marker of Low Risk of Chronic Rejection in Lung Transplant Recipients: A Clinical Prospective Study. Am J Transplant, 2015; 15(2): 461-71.
        35. R. Rizzo, V. Gentili, A. Rotola, D. Bortolotti, E. Cassai, D. Di Luca. Implication of HLA-C and KIR Alleles in Human Papillomavirus Infection and Associated Cervical Lesions. Viral immunol 27(9):468-70.
        36. F. Morandi, E. Fainardi, R. Rizzo, N. Rouas-Freiss. The role of HLA-class Ib molecules in immune-related diseases, tumors, and infections. J Immunol Res. 2014; 2014: 231618.
        37. A. Borghi, R. Rizzo, M. Corazza, A.M. Bertoldi, D. Bortolotti, G. Sturabotti, A. Virgili, D. Di Luca. HLA-G 14-bp polymorphism: a possible marker of systemic treatment response in psoriasis vulgaris? Preliminary results of a retrospective study. Dermatol Ther 2014; 27(5): 284-9.
        38. E. Alegre, R. Rizzo, D. Bortolotti, S. Fernandez-Landázuri, E. Fainardi, A. González. Some basic aspects of HLA-G biology. J Immunol Res 2014; 2014: 657625.
        39. R. Rizzo, N. Malagutti, D. Bortolotti, V. Gentili, A. Rotola, E. Fainardi, T. Pezzolo, C. Aimoni, S. Pelucchi, D. Di Luca, A. Pastore. Infection and HLA-G molecules in nasal polyposis. J Immunol Res. 2014; 2014: 407430. doi: 10.1155/2014/407430.
        40. N. Ben Fredj,  R. Rizzo D. Bortolotti, F. Nefzi, S. Chebel, A. Rotola, M. Frih-Ayed, D. Di Luca, M. Aouni. Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibility. J Neuroimmunol. 2014; 271(1-2): 30-5.
        41. D. Bortolotti, V. Gentili, A. Rotola, D. Di Luca, R. Rizzo. Implication of HLA-G 3' untranslated region polymorphisms in human papillomavirus infection. Tissue Antigens 2014; 83: 113-8.
        42. R. Rizzo , V. Audrito , P. Vacca , D. Rossi , D. Brusa , M. Stignani , D. Bortolotti , G. D' Arena , M. Coscia , L. Laurenti , F. Forconi , G. Gaidano , MC. Mingari , L. Moretta , F. Malavasi , S. Deaglio . HLA-G is a component of the CLL escape repertoire to generate immune suppression: impact of HLA-G 14 bp (rs66554220) polymorphism. Haematologica,  2014; 99(5):888-96.
        43. D. Bortolotti, V. Gentili, A. Rotola, E. Cassai, R. Rizzo, D. Di Luca. Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions. World J Methodol 2014; 4(1):11-25.
        44. R. Rizzo. Immunosupressive properties of HLA-G molecules produced by mesenchymal stromal cells. Transplant Technol Res 2013; 3:e127.
        45. D. Campioni, D. Bortolotti, O. Baricordi, R. Rizzo. Multipotent stromal cells skew monocytes towards an anti-inflammatory function: a role for HLA-G molecules. Haematologica, 2013; 98: e114. doi: 10.3324/haematol.2013.090092.
        46. F. Morandi, C.Venturi, R. Rizzo, M.Castellazzi, E. Baldi, ML. Caniatti, MR. Tola, E.Granieri, E. Fainardi, A. Uccelli, V. Pistoia. Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. J Neuroimmune Pharmacol. 2013; 8: 944-55. doi: 10.1007/s11481-013-9459-3.
        47. R. Rizzo, A. Trentini, D. Bortolotti, M. C. Manfrinato, A. Rotola, M. Castellazzi, L. Melchiorri, D. Di Luca, F. Dallocchio, E. Fainardi, T. Bellini. Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding. Mol Cel Biochem 2013;  381: 243-55.
        48. E. Caselli, R. Rizzo, A. Ingianni, P. Contini, R. Pompei, D. Di Luca. High prevalence of HHV8 infection and specific killer cell immunoglobulin-like receptors allotypes in Sardinian patients with type 2 diabetes mellitus. J Medical Virol 2014; 86(10): 1745-51.
        49. M. Abonnenc, N. Manaresi, M. Borgatti, G. Medoro, E. Fabbri, A. Romani, L. Altomare, M. Tartagni, R. Rizzo, O. Baricordi, E. Tremante, E. Lo Monaco, P. Giacomini, R .Guerrieri, R. Gambari. (2013). Programmable interactions of functionalized single bioparticles in a dielectrophoresis-based microarray chip. Anal Chem 2013; 85: 8219-24.
        50. R. Rizzo, D. Bortolotti, O. Baricordi, I. Farina, M. Padovan, M. Govoni. Can HLA-G predict disease course in RA patients? Int J Clinical Rheumatol 2013; 8, 627-38.
        51. R. Rizzo, O. Baricordi. Focus on the importance of soluble human leukoctye antigen G as a marker for embryo selection in assisted reproductive Technologies. Fertil Steril, 2013;100: e43.
        52. R. Rizzo, I. Farina, D. Bortolotti, E. Galuppi, A. Rotola, L. Melchiorri, G. Ciancio, D. Di Luca, M. Govoni. HLA-G may predict the disease course in patients with early rheumatoid arthritis. Hum Immunol 2013; 74: 425-432.
        53. R. Rizzo. Advances in Mesenchymal Stromal Cell Properties. Transplant Technol Res 2012; 2:3.
        54. 54.  E. Caselli, MC. Zatelli, R. Rizzo, S. Benedetti, D. Martorelli, G. Trasforini, E. Cassai, EC. degli Uberti, D. Di Luca, R. Dolcetti. Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis. Plos Pathogens 2012; 8: 1-10.
        55. R. Rizzo, D. Bortolotti, OR. Baricordi, E. Fainardi. New insights into HLA-G and inflammatory diseases. Inflamm Allergy Drug Targets 2012; 11: 448-63.
        56. A. Dardano, R. Rizzo, A. Polini, M. Stignani, S. Tognini, G. Pasqualetti, S. Ursino, C. Colato, M. Ferdeghini, OR. Baricordi, F. Monzani. Soluble Human Leukocyte Antigen-G and Its Insertion/Deletion Polymorphism in Papillary Thyroid Carcinoma: Novel Potential Biomarkers of Disease? J Clin Endocrinol Metab 2012; 97: 4080-6.
        57. R. Rizzo, D. Bortolotti, NB. Fredj, A. Rotola, F. Cura, M. Castellazzi, C. Tamborino, S. Seraceni, E. Baldi, L. Melchiorri, MR. Tola, E. Granieri, OR. Baricordi, E. Fainardi. Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. Hum Immunol 2012; 73: 1140-6.
        58. R. Rizzo, Gentili V, Casetta I, Caselli E, De Gennaro R, Granieri E, Cassai E, Di Luca D, Rotola A. Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression. J Neuroimmunol 2012; 251: 55-64.
        59. D. Bortolotti, V. Gentili, L. Melchiorri, A. Rotola, R. Rizzo. An accurate and reliable Real Time SNP genotyping assay for the HLA-G +3142bp C>G polymorphism. Tissue Antigens 2012; 80: 259-62.
        60. M. Buzzi, F. Alviano, D. Campioni,  M. Stignani, L. Melchiorri, A. Rotola, P. Tazzari, F. Ricci, C. Vaselli, A. Terzi, P.P. Pagliaro, A. Cuneo, F. Lanza, A. Bontadini, O.R. Baricordi, R. Rizzo. Umbilical Cord Blood CD34+cell-derived progeny produces HLA-G molecules with immunomodulatory functions. Hum Immunol 2012; 73: 150-5.
        61. N. Ben Fredj, A. Rotola, F. Nefzi, S. Chebel, R. Rizzo, E. Caselli, M. Frih-Ayed, D. Di Luca, M. Aouni. Identification of Human Herpesviruses 1 to 8 in Tunisian Multiple Sclerosis patients and healthy blood donors. J Neurovirol 2012; 18: 12-9.
        62. P. Chiusolo, S. Bellesi, N. Piccirillo, S. Giammarco, S. Marietti, D. De Ritis, E. Metafuni, M. Stignani, O.R. Baricordi, S. Sica, G. Leone, R. Rizzo. The role of HLA–G 14bp polymorphism in allogeneic haematopoietic stem cell transplantation after short-term course methotrexate for graft-versus host disease prophylaxis. Bone Marrow Transpl 2012; 47: 120-4.
        63. A. Zelante, R. Borgoni, C. Galuppi, V. Cifalà, L. Melchiorri, S. Gullini, O. Baricordi, R. Rizzo. Therapy modifies HLA-G secretion differently in Crohn's disease and ulcerative colitis patients. Inflamm Bowel Dis 2011; 17: E94-95.
        64. R. Rizzo, Vercammen M, van de Velde H, Horn PA, Rebmann V. The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells. Cell Mol Life Sci. 2011; 68: 341-52.
        65. R. Rizzo, G. Lanzoni, M. Stignani, D. Campioni, F. Alviano, F. Ricci, P.L. Tazzari, L. Melchiorri, S. Zaccaria Scalinci, A. Cuneo, L. Bonsi, F. Lanza, G.P. Bagnara, O.R. Baricordi. A simple method to identify bone marrow mesenchymal stromal cells with a high immunosuppressive potential. Cytotherapy 2011; 13: 523-7.
        66. R. Rizzo, F. Spaggiari, M. Indelli, G. Lelli, OR. Baricordi, P. Rimessi, A. Ferlini. Association of CYP1B1 with hypersensitivity induced by Taxane therapy in breast cancer patients. Breast Cancer Res Treat. 2010; 124: 593-8.
        67. A. Ongaro, M. Stignani, A. Pellati, L. Melchiorri, L. Massari, G. Caruso, M. De Mattei, A. Caruso, OR. Baricordi, R. Rizzo. Human leukocyte antigen-G molecules are constitutively expressed by synovial fibroblasts and upmodulated in osteoarthritis. Hum Immunol. 2010; 71: 342-50.
        68. A. Solini, E. Muscelli, M. Stignani, L. Melchiorri, E. Santini, C. Rossi, BD. Astiarraga, R. Rizzo, OR Baricordi. Soluble Human Leukocyte Antigen-G Expression and Glucose Tolerance in Subjects with Different Degrees of Adiposity. J Clin Endocrinol Metab. 2010; 95: 3342-6.
        69. E. Fainardi, R. Rizzo, A. Lupato, V. Ramponi, G. De Santis, F. Garofano, M. Stignani, C. Tamborino, M. Castellazzi, I. Casetta, OR. Baricordi. Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage. Acta Neurochir Suppl. 2010; 106: 141-5.
        70. R. Rizzo, M. Stignani, L. Melchiorri, O.R. Baricordi. The possible role of HLA-G molecules in human oocyte/embryo secretome. Hum Immunol 2009; 70: 970-5.
        71. E. Fainardi, R. Rizzo, M. Castellazzi, M. Stignani, E. Granieri, O.R. Baricordi. Potential role of soluble HLA-G molecules in multiple sclerosis. Human Immunol 2009; 70: 981-7.
        72. R. Rizzo, M. Stignani, L. Melchiorri, O.R. Baricordi. Comment on “Experimental Extracorporeal Photopheresis Inhibits the Sensitization and Effector Phases of Contact Hypersensitivity via Two Mechanisms: Generation of IL-10 and Induction of Regulatory T Cells”. J Immuonol 2009; 182: 4497.
        73. G. Lanzoni, F. Alviano, C. Marchionni, L. Bonsi, R. Costa, L. Foroni, G. Roda, A. Belluzzi,  F. Ricci, P.L. Tazzari, R. Rizzo, F. Lanza, O.R. Baricordi, G. Pasquinelli, E. Roda, G.P. Bagnara. Human multipotent mesenchymal stromal cells with trophic and immunoregulatory functions can be isolated from intestinal tissues: implications for Inflammatory Bowel Diseases. Cytotherapy 2009; 11: 1020-31.
        74. R. Rizzo, A.S. Andersen, M.R. Lassen, H.C. Sørensen, T. Bergholt, M.H. Larsen, L. Melchiorri, M. Stignani, O.R. Baricordi, T.V.F. Hviid. Soluble Human Leukocyte Antigen-G Isoforms in Maternal Plasma in Early and Late Pregnancy. Am J Reprod Immunol 2009; 62: 320-38.
        75. R. Rizzo, D. Ferrari, L. Melchiorri, M. Stignani, S. Gulinelli, O.R. Baricordi, F. Di Virgilio. Extracellular ATP acting at the P2X7 receptor inhibits secretion of soluble HLA-G  from human monocytes. J Immunol 2009; 183: 4302-11.
        76. R. Rizzo, M.B. Dal Canto, M. Stignani, R. Fadini, D. Fumagalli, M. Mignini Renzini, M. Borgatti, R. Gambari, O.R. Baricordi. Production of sHLA-G molecules by “in vitro” matured cumulus-oocyte complex. Int J Mol Med 2009; 24: 523-30.
        77. R. Rizzo, S. Quintavalle, M. Stignani, F. Franzè, L. Melchiorri, E. De Rosa, OR. Baricordi. Reduced production of anti-inflammatory soluble HLA-G molecules in styrene exposed workers. Environmental Toxicol Pharmacol 2009; 27: 303-5.
        78. R. Rizzo. HLA-G molecules in pregnancy and their possible role in assisted reproductive technology. Expert Rev Obstet Gynecol 2009; 4: 455-70.
        79. R. Rizzo, M. Stignani, P. Amoudruz, C. Nilsson, L. Melchiorri, O. Baricordi, E. Sverremark-Ekström. Allergic women have reduced sHLA-G plasma levels at delivery. Am J Reprod Immunol 2009; 61: 368-76.
        80. CE. Mapp, S. Ferrazzoni, R. Rizzo, D. Miotto, M. Stignani, P. Boschetto, P. Maestrelli, OR. Baricordi. Soluble HLA-G and IL-10 levels in isocyanate asthma, non occupational asthma and rhinitis. Clin Exp Allergy 2009; 39: 812-9.
        81. D. Campioni, R. Rizzo, M. Stignani, L. Melchiorri, L. Ferrari, S. Moretti, A. Russo, GP. Bagnara, F. Alviano, G. Lanzoni, A. Cuneo, OR. Baricordi, F. Lanza. A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs. Cytometry B Clin Cytom 2009; 76: 225-30.
        82. M. Borgatti*, R. Rizzo*, MB Dal Canto, D. Fumagalli, M. Mignini Renzini, M. Stignani, OR. Baricordi, R. Gambari. Release of sICAM-1 in oocytes and in vitro fertilized human embryos. PloS One 2008; 3(12): e3970. *The first two authors contributed equally to the work.
        83. A. Borghi, E. Fogli, M. Stignani, L. Melchiorri, E. Altieri, OR. Baricordi, R. Rizzo, A. Virgili. Soluble HLA-G and interleukin 10 levels in plasma of psoriatic patients:preliminary study on a possible correlation between generalized immune status, treatments and disease. Arch Dermatol Res 2008; 300(10): 551-9.
        84. O.R. Baricordi, M. Stignani, L. Melchiorri, R. Rizzo. HLA-G and inflammatory diseases. Inflamm Allergy Drug Targets 2008; 7(2): 67-74.
        85. N. Malagutti, C. Aimoni,  A.  Balboni, M. Stignani, L. Melchiorri,  M. Borin, A. Pastore, R. Rizzo, OR.  Baricordi. Decreased production of HLA-G molecules in sinonasal polyposis. Am J Rhinol 2008; 22(5): 468-73.
        86. R. Rizzo (Corresponding author); D. Campioni; F. Lanza; OR. Baricordi. Cotransplantation of mesenchymal cells and a higher relapse rate: a role for HLA-G molecules? Leukemia 2008; 22(12): 2273.
        87. R. Rizzo, D. Campioni. M. Stignani, G.P. Bagnara, L. Bonsi; F. Alviano, G. Lanzoni, S. Moretti, A. Cuneo, F. Lanza, O.R. Baricordi. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells. Cytotherapy 2008; 10(4): 364-75.
        88. R. Rizzo, T. V. F. Hviid, M. Govoni, M. Padovan, M. Rubini, L. Melchiorri, M. Stignani, S. Carturan, M. T. Grappa, M. Fotinidi, S. Ferretti, A. Voss, H. Laustrup, P. Junker, F. Trotta, O. R. Baricordi. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 2008; 71(6): 520-9.
        89. M. Borgatti, R. Rizzo, I. Mancini, F. Fabbri, O. Baricordi, R. Gambari. Antibody-antigen interactions in dielectrophoresis buffers for cell manipulation on dielectrophoresis-based Lab-on-chip devices. Minerva Biotec 2007; 19.
        90. E. Fainardi, R. Rizzo, L. Melchiorri, M. Stignani, M. Castellazzi, C. Tamborino, E. Paolino, MR. Tola, E. Granieri, OR. Baricordi. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis 2008; 14(4):446-54.
        91. R. Rizzo, L. Melchiorri, L. Simone, M. Stignani, A. Marzola, S. Gullini, OR. Baricordi. Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn’s disease: a noninvasive diagnostic tool? Inflamm Bowel Dis 2008; 14(1): 100-105.
        92. E. Fainardi, R. Rizzo, L. Melchiorri, M. Stignani, M. Castellazzi, L. Caniatti, E. Baldi, MR. Tola, E. Granieri, OR. Baricordi Soluble HLA-G molecules are preponderantly released as HLA-G5 isoforms in CSF of patients with relapsing-remitting multiple sclerosis. J Neuroimmunol 2007; 192 (1-2): 219-25.
        93. F. Trotta, M. Govoni, R. Rizzo, OR. Baricordi. In rheumatoid arthritis a polymorphism in the HLA-G gene concurs in the clinical response to MTX treatment. Ann Rheum Dis 2007; 66(8):1125-6.
        94. R. Rizzo, B. Fuzzi, M. Stignani, L. Criscuoli, L. Melchiorri, S. Dabizzi, D. Campioni, F. Lanza, A. Marzola, F. Branconi, I. Noci, OR. Baricordi. Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? J Reprod Immunol 2007; 74(1-2): 133-42.
        95. R. Rizzo, L. Melchiorri, M. Stignani, OR. Baricordi HLA-G expression is a fundamental prerequisite to pregnancy. Human Immunol 2007; 68(4):244-50.
        96. F. Lanza, D. Campioni, S. Moretti, L. Ferrari, R. Rizzo, OR. Baricordi, A. Cuneo. Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchimal stromal cells from patients affected by acute lymphoproliferative disorders. Leukemia 2007; 21(2): 378-81.
        97. R. Rizzo, M. Rubini, M. Govoni, M. Padovan, L. Melchiorri, M. Stignani, S. Carturan, S. Ferretti, F. Trotta, OR. Baricordi. HLA–G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenet Genomics 2006; 16(9): 615-23.
        98. TVF. Hviid, R. Rizzo, L. Melchiorri, M. Stignani, OR. Baricordi. Polymorphism in the 5’-upstream regulatory and 3’-untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Human Immunol 2006; 67(1-2): 53-62.
        99. E. Fainardi, R. Rizzo, L. Melchiorri, M. Castellazzi, E. Paolino, M.R. Tola, E.Granieri, O.R. Baricordi. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis. Multiple Sclerosis 2006; 12(1): 2-12.
        100. R. Rizzo, L. Melchiorri, P.L. Tazzari, C. Tassi, M. Soli, M. Lunghi, M. Belloni, R. Conte, O.R. Baricordi. Increased production of soluble HLA-G molecules in stimulated peripheral blood mononuclear cells following extracorporeal photopheresis.  Is it a mechanism involved in the therapeutic effect of the procedure?  J Clin Apheresis 2005; 20(4): 222-4.
        101. L. Criscuoli, R. Rizzo, B. Fuzzi, L. Melchiorri, A. Menicucci, C. Cozzi, S. Dabizzi, O. R. Baricordi, I. Noci.  Lacking of HLA-G expression in early embryos is not related to germinal defects or impairment in IL-10 embryos production. Gynecol Endocrinol 2005; 20(5): 264-9.
        102. R. Rizzo, T.V. Hviid, M. Stignani, A. Balboni, M.T. Grappa, L. Melchiorri, O.R. Baricordi. HLA-G genotype is associated with IL-10 levels in activated PBMC. Immunogenetics 2005; 57(3-4): 172-81.
        103. R. Rizzo, C.E. Mapp, L. Melchiorri, P. Maestrelli, A. Visentin, I. Bononi, D. Miotto, O.R. Baricordi. Defective production of soluble HLA-G molecules by peripheral blood monocyte in asthmatic patients. J Allergy Clin Immunol 2005; 115(3): 508-13.
        104. I. Noci, B. Fuzzi, R. Rizzo, L. Melchiorri, L. Criscuoli, S. Dabizzi, R. Biagiotti, C. Cozzi, A. Menicucci, O.R. Baricordi. Embryonic soluble HLA-G as a potential marker of embryo viability. Hum Reprod 2004; 21: 138-46.
        105. A. Solini, P. Chiozzi, A. Morelli, E. Adinolfi, R. Rizzo, O.R. Baricordi, F. Di Virgilio.  Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes. Arterioscl Thromb Vas 2004; 24:1240-5.
        106. T.V.F. Hviid, R. Rizzo, O.B. Christiansen, L. Melchiorri, A. Lindhard and O.R.Baricordi.  HLA-G and IL-10 in serum in relation to HLA-G genotype polymorphism.  Immunogenetics 2004; 56: 135-41.
        107. E. Fainardi, R. Rizzo, L. Melchiorri, M.Castellazzi, V.Govoni, L.Caniatti, E.Paolino, MR. Tola, E.Granieri and O.R. Baricordi.  Beneficial effect of interferon-β 1b treatment in patients with relapsing-remitting multiple sclerosis is associated to an increase in serum levels of soluble HLA-I molecules during the first three months of therapy. J Neuroimmunol 2004; 148:206-11.
        108. E. Fainardi, R. Rizzo, L. Melchiorri, L. Vaghi, M. Castellazzi, A. Marzola, V. Govoni, E. Paolino, M.R. Tola, E. Granieri, O.R. Baricordi. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis : relationship with CSF soluble HLA–I and IL -10 concentrations and MRI findings. J. Neuroimmunol. 2003; 142: 149-58.
        109. E. Fainardi, E. Granieri, M.R. Tola, L. Melchiorri, L. Vaghi, R. Rizzo, M. Castellazzi, S. Ceruti, E. Paolino, O.R. Baricordi. Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules. J. Neuroimmunol. 2002; 133 (1-2): 151-9.
        110. L. Melchiorri, A. Martini, R. Rizzo, A. Berto, E. Adinolfi, O.R. Baricordi. Human Leukocyte Antigen -A, -B,-C and -DR Alleles and Soluble Human Leukocyte Antigen Class I Serum Level in Ménière Disease. Acta Oto-laryngol. 2002; Suppl 548: 26-9.
        111. B. Fuzzi*, R. Rizzo*, L. Criscuoli, I. Noci, L. Melchiorri, B. Scarselli, E. Bencini, A. Menicucci, O.R. Baricordi. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol. 2002; 32: 311-5 *The first two authors contributed equally to the work
              Azioni sul documento